샘플 요청 목록

 카트 문의
시장보고서
상품코드
1565048

세계의 신경과 기기 시장

Neurology Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경과 기기 세계 시장은 2030년까지 187억 달러에 달할 것으로 전망

2023년 126억 달러로 추정되는 신경과 기기 세계 시장은 2023-2030년의 분석 기간 동안 연평균 5.9% 성장하여 2030년에는 187억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 뇌척수액(CSF) 관리 기기는 CAGR 5.7%를 기록하여 분석 기간 종료 시점에 71억 달러에 도달할 것으로 예상됩니다. 신경 자극 기기 부문은 분석 기간 동안 CAGR 6.7%의 성장률을 나타낼 것으로 추정됩니다.

미국 시장은 33억 달러, 중국은 CAGR 9.9%로 성장 전망

미국의 신경과 기기 시장은 2023년 33억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 44억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 9.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.3%와 6.0%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 2.9%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 신경과 기기 시장 - 주요 동향 및 촉진요인 요약

신경과 기기는 신경질환 치료를 어떻게 진행하고 있을까?

신경과 기기는 간질과 파킨슨병에서 뇌졸중과 외상성 뇌손상에 이르기까지 다양한 신경 질환의 진단, 모니터링 및 치료에 필수적인 역할을 하고 있습니다. 신경 자극기, 신경 진단 시스템, 뇌척수액(CSF) 관리 장치 등 다양한 기술을 포함하고 있습니다. 인구 고령화와 정신질환에 대한 인식이 높아지면서 신경질환이 증가함에 따라 이들 기기에 대한 수요가 급증하고 있습니다. 운동 장애를 치료하는 뇌심부자극요법(DBS)이나 뇌파계(EEG)와 같은 첨단 영상 기술과 같은 혁신은 보다 정확하고 덜 침습적인 진단과 치료법을 가능하게 하여 환자들의 치료 결과를 크게 개선하고 있습니다.

신경학 기기의 혁신을 형성하는 데 있어 기술은 어떤 역할을 하는가?

신경과 기기의 발전은 로봇 공학, 인공지능(AI), 소형화 등의 기술 혁신과 밀접한 관련이 있으며, AI를 활용한 진단 도구는 신경 질환의 조기 발견 능력을 향상시키고, 로봇 보조 수술은 신경 외과 수술의 정확성과 안전성을 향상시키고 있습니다. 또한, 편두통이나 우울증 등의 치료에 저주파 전기 펄스를 공급하는 웨어러블 신경 자극기는 약물 치료를 대체할 수 있는 비침습적 치료법을 제공합니다. 소형화로 인해 더 작은 크기의 이식형 장치의 개발이 가능해지면서 DBS와 같은 치료가 환자들에게 더 편안하고 친숙하게 다가갈 수 있게 되었습니다. 이러한 발전은 신경과 기기의 능력을 확장할 뿐만 아니라 신경 질환을 앓고 있는 사람들의 삶의 질을 향상시키고 있습니다.

인구통계와 헬스케어 트렌드가 신경과 기기 시장에 어떤 영향을 미치고 있는가?

신경과 기기 수요를 촉진하는 주요 요인으로 특히 고령화 사회에서의 신경질환 유병률 증가를 꼽을 수 있습니다. 알츠하이머병, 뇌졸중, 파킨슨병과 같은 증상은 점점 더 흔해지고 있으며, 진단과 장기적인 관리 모두에 첨단 장비가 필요합니다. 또한, 의료비 지출 증가와 신경학적 치료의 질 향상에 대한 관심이 높아지면서 새로운 기술과 치료법에 대한 투자가 증가하고 있습니다. 신흥 시장에서도 의료 인프라가 개선되고 신경 질환에 대한 인식이 높아짐에 따라 신경 장비에 대한 수요가 급증하고 있습니다. 한편, 규제 당국은 치료 효과가 큰 신경과 기기에 대한 승인 절차를 간소화하고 있어 시장 성장을 더욱 촉진하고 있습니다.

신경과 기기 시장의 성장은 여러 가지 요인에 의해 이루어진다

신경과 기기 시장의 성장은 여러 요인, 특히 고령화 사회에서의 신경질환 발병률 증가로 인해 첨단 진단 및 치료 장비에 대한 수요가 증가하고 있으며, AI 기반 진단, 로봇 보조 수술, 웨어러블 신경자극기 등의 기술 발전으로 치료의 정확성과 효과성이 향상되고 있습니다. 정확성과 유효성이 향상되고 있습니다. 또한, 특히 신흥 시장에서의 의료비 지출 증가로 인해 이러한 첨단 기기들이 더욱 친숙하게 다가오고 있습니다. 또한, 비침습적 치료 옵션과 환자 예후를 개선하는 추세로 인해 의료 서비스 제공업체들은 더욱 새롭고 정교한 신경과 기기를 도입하고 있습니다. 규제 당국의 혁신적 신경과 기기에 대한 지원이 확대되고 있는 것도 시장을 더욱 활성화시키고 있습니다.

조사 대상 기업 예시(총 42건)

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.10.08

Global Neurology Devices Market to Reach US$18.7 Billion by 2030

The global market for Neurology Devices estimated at US$12.6 Billion in the year 2023, is expected to reach US$18.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Cerebrospinal Fluid Management Devices, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$7.1 Billion by the end of the analysis period. Growth in the Neurostimulation Devices segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.9% CAGR

The Neurology Devices market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Neurology Devices Market - Key Trends & Drivers Summarized

How Are Neurology Devices Advancing the Treatment of Neurological Disorders?

Neurology devices have become integral in diagnosing, monitoring, and treating a wide range of neurological disorders, from epilepsy and Parkinson's disease to stroke and traumatic brain injury. These devices encompass a broad range of technologies, including neurostimulation devices, neurodiagnostic systems, and cerebrospinal fluid management equipment. With neurological disorders on the rise due to aging populations and increasing awareness of mental health conditions, the demand for these devices has grown exponentially. Innovations such as deep brain stimulation (DBS) for treating movement disorders, as well as advanced imaging technologies like electroencephalograms (EEGs), are enabling more precise and less invasive diagnosis and treatment options, significantly improving patient outcomes.

What Role Does Technology Play in Shaping Neurology Device Innovations?

The advancement of neurology devices is closely tied to technological innovations in fields like robotics, artificial intelligence (AI), and miniaturization. AI-powered diagnostic tools are enhancing the ability to detect neurological disorders early, while robotic-assisted surgery is increasing the precision and safety of neurosurgical procedures. Additionally, wearable neurostimulation devices, which deliver low-frequency electrical pulses to treat conditions like migraines or depression, are providing non-invasive alternatives to medication. Miniaturization has enabled the development of smaller, implantable devices, making treatments like DBS more comfortable and accessible for patients. These advancements are not only expanding the capabilities of neurology devices but also improving the quality of life for individuals with neurological conditions.

How Are Demographic and Healthcare Trends Impacting the Neurology Devices Market?

The growing prevalence of neurological disorders, particularly among aging populations, is a key factor driving demand for neurology devices. Conditions such as Alzheimer’s disease, stroke, and Parkinson’s are becoming more common, requiring advanced devices for both diagnosis and long-term management. In addition, increased healthcare spending and a rising focus on improving the quality of neurological care are spurring investments in new technologies and therapies. Emerging markets are also seeing a surge in demand for neurology devices as healthcare infrastructure improves, and awareness of neurological disorders rises. Meanwhile, regulatory bodies are streamlining approval processes for neurology devices that demonstrate significant therapeutic benefits, further driving market growth.

The Growth in the Neurology Devices Market Is Driven by Several Factors

The growth in the neurology devices market is driven by several factors, including the rising incidence of neurological disorders, particularly in aging populations, which is creating greater demand for advanced diagnostic and therapeutic devices. Technological advancements, such as AI-driven diagnostics, robotic-assisted surgeries, and wearable neurostimulation devices, are enhancing the precision and effectiveness of these treatments. Additionally, increasing healthcare expenditure, particularly in emerging markets, is making these advanced devices more accessible. Moreover, the trend toward non-invasive treatment options and improved patient outcomes is prompting healthcare providers to adopt newer, more sophisticated neurology devices. The expanding regulatory support for innovative neurology devices is further fueling the market, as faster approvals are encouraging the adoption of cutting-edge technologies.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Neurology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Neurological Disorders Driving Device Demand
    • Technological Advancements in Neurostimulation Devices and Implants
    • Increasing Use of Wearable Neurology Devices for Continuous Monitoring
    • Growing Adoption of AI and Machine Learning in Neurological Diagnostics
    • Expansion of Minimally Invasive Surgery in Neurosurgery Devices
    • Advances in Brain-Computer Interface (BCI) Technology
    • Increasing Use of Telemedicine in Neurology and Remote Monitoring Devices
    • Development of Portable Imaging Systems for Point-of-Care Diagnostics
    • Growth in Geriatric Population Leading to Higher Incidence of Neuro Disorders
    • Rising Research Investments in Neuroscience and Brain Mapping Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cerebrospinal Fluid Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cerebrospinal Fluid Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Neurostimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제